The 43rd Annual JP Morgan Healthcare Conference took place in San Francisco, California on January 13-16, 2025. The event is the largest and most informative health care investment symposium in the industry. This year’s invitation-only conference provided key insights into the evolving strategies, pipeline advancements, and market trends shaping the biopharmaceutical industry, including acquisitions, innovative pipeline developments, and strategic shifts to navigate a rapidly changing healthcare landscape.

In this report GlobalData provides an in-depth analysis of the key themes, strategic moves, and market dynamics presented at the conference, offering insights into how major players are positioning themselves for future growth. The report covers pharma (big pharma, mid cap, and small cap), CDMOs, tech, medical device and healthcare.

Reasons to Buy

Overview of market trends and developments occurring in the Pharma, Medical Device and CMO Industries.

Detailed discussion of deal-making and funding occuring at key player companies.

Analysis of geopolitical challenges and the looming Biosecure Act.